ISSN: 2475-7640

Journal de transplantation clinique et expérimentale

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

An Overview on Transplantation Tolerance

Helen Cribb

Organ transplantation has become a common practice in modern medicine. With advancements in surgical techniques and immunosuppressive therapies, the success rates of organ transplantation have significantly increased, providing patients with a new lease of life. However, transplantation is not without its challenges. The immune system of recipients recognizes transplanted organs as foreign, triggering an immune response that can lead to graft rejection. This process is mediated by various immune cells and molecules, including T cells, B cells, antibodies, cytokines, and complement proteins. To prevent graft rejection, patients receive immunosuppressive drugs that suppress their immune system, but these drugs have side effects and can increase the risk of infections and cancer. Therefore, there is a need for alternative strategies to induce transplantation tolerance, which refers to the state of immune unresponsiveness towards the transplanted organ. Transplantation tolerance can eliminate or reduce the need for immunosuppressive drugs and improve the long-term outcomes of transplantation. In this article, we will review the current understanding of transplantation tolerance and the strategies that are being developed to achieve it.